Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

930
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
930
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

151
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
151
Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

90
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
90
Factors Affecting Protein-Drug Binding: Drug-Related Factors01:18

Factors Affecting Protein-Drug Binding: Drug-Related Factors

159
Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
159
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

321
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
321
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Environmental enrichment is associated with enhanced novel object recognition performance and an increased proportion of smooth endoplasmic reticulum-containing spines in the dentate gyrus of Septin3<sup>-/-</sup> mice.

Molecular brain·2026
Same author

Comparison of area under the concentration-time curve estimations between Practical Antimicrobial Therapeutic Drug Monitoring (PAT) versions 3 and 4 for vancomycin using two-point sampling.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy·2026
Same author

Exploring the influence of sex on <i>idiosyncratic</i> DILI: impact on risk assessment.

Expert opinion on drug metabolism & toxicology·2026
Same author

Association of Statin Use with Reduced Primary Liver Cancer Risk, Independent of Age and Cirrhosis Protection in MASLD.

Cancers·2026
Same author

Development of a risk prediction model for vancomycin-associated acute kidney injury: a multicentre retrospective study.

The Journal of antimicrobial chemotherapy·2026
Same author

Age and sex influence transcriptomic responses to statin therapy that control liver aging during systemic metabolic dysfunction.

Hepatology (Baltimore, Md.)·2026
Same journal

Methods for incorporating test result information within the high-dimensional propensity score framework: application in UK electronic health record data.

BMC medical research methodology·2026
Same journal

Sparse multi-way DMDC for longitudinal classification in high dimension low sample size data.

BMC medical research methodology·2026
Same journal

Tree-based exploratory identification of predictive biomarkers in non-randomized data.

BMC medical research methodology·2026
Same journal

Comparative evaluation of interrupted time series analytical methods for healthcare quality improvement research: a Monte Carlo simulation study.

BMC medical research methodology·2026
Same journal

Methodological advances in claims-based dementia algorithms: integrating medication and clinical data for medicare populations.

BMC medical research methodology·2026
Same journal

An interpretable XGboost algorithm for predicting 30-day mortality in acute pancreatitis using routine biomarkers.

BMC medical research methodology·2026
See all related articles

Related Experiment Video

Updated: Aug 5, 2025

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.2K

Statistical methods for exploring spontaneous adverse event reporting databases for drug-host factor interactions.

Zhiyuan Lu1, Ayako Suzuki2,3, Dong Wang4

  • 1Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, Arkansas, USA.

BMC Medical Research Methodology
|March 27, 2023
PubMed
Summary
This summary is machine-generated.

New statistical methods can identify how drug toxicity varies by patient factors like age and sex using adverse event reports. This advances personalized drug safety by revealing drug-host interactions and disparities in adverse events.

Keywords:
Drug-host factor interactionsFAERSLikelihood ratio testsPostmarket surveillanceSpontaneous reporting adverse event databases

More Related Videos

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.7K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

11.9K

Related Experiment Videos

Last Updated: Aug 5, 2025

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.2K
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.7K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

11.9K

Area of Science:

  • Pharmacovigilance
  • Biostatistics
  • Drug Safety

Background:

  • Drug toxicity varies among patients due to individual susceptibility and drug-host interactions.
  • Personalized drug safety is crucial but under-studied due to data and methodological limitations.
  • Spontaneous adverse event reporting systems offer vast data for exploring risk disparities by host factors.

Purpose of the Study:

  • To develop and validate a statistical framework for analyzing spontaneous adverse event databases.
  • To detect drug-host interactions and identify risk disparities in adverse drug events based on host factors.
  • To adapt existing safety signal detection methods for exploring demographic disparities.

Main Methods:

  • Proposed four statistical methods: likelihood ratio test, normal approximation test, and two subgroup ratio tests.
  • Applied methods to simulated data and the FDA Adverse Event Reporting System (FAERS).
  • Investigated sex and age disparities in liver events linked to specific drug classes.

Main Results:

  • Simulation results confirmed that likelihood ratio and normal approximation tests effectively detect disparities while controlling error rates.
  • Real-world data analysis identified drugs with significant sex/age disparities in liver toxicity.
  • The methods can pinpoint adverse events with unbalanced host factor distributions for specific drugs.

Conclusions:

  • Spontaneous adverse event databases are valuable resources for drug safety research, despite data processing challenges.
  • The proposed statistical methods facilitate the investigation of drug-host interactions in drug toxicity.
  • This work enables a deeper understanding of personalized drug safety by analyzing large-scale adverse event data.